Terrorism Expert Available To Discuss Attack On Charlie Hebdo In France
Georgia State University
Researchers have taken a comprehensive look at the growth of crowd science, describing the considerable value of donated time and noting the limitations of nonprofessional research assistance.
Pfizer Inc. has granted nearly $850,000 to Georgia State University’s School of Public Health to partner with Chinese health officials to expand tobacco control efforts to major cities in China.
The term Alzheimer's is frequently used to describe all dementias even though there are many different causes for dementia. Lewy body dementia affects 1.4 million American and is frequently misdiagnosed.
Officials must use policy, tax and other regulatory tools to stem youth smoking and health effects of tobacco use
The Paleolithic diet, or caveman diet, a weight-loss craze in which people emulate the diet of plants and animals eaten by early humans during the Stone Age, gives modern calorie-counters great freedom because those ancestral diets likely differed substantially over time and space, according to researchers at Georgia State University and Kent State University.
A Georgia Tech study notes that copyright law is navigated on a daily basis by Internet users, and that for amateur creative types publishing on the Web’s largest creative venues, they often don’t trust the websites to safeguard their art.
When someone you know is wearing an unfamiliar hat, you might not recognize them. Georgia Institute of Technology researchers are using just such a disguise to sneak biomaterials containing peptide signaling molecules into living animals.
Cigarette smoking generates as much as $170 billion in annual health care spending in the United States, according to a new study co-authored by researchers at Georgia State University’s School of Public Health, the Centers for Disease Control and Prevention (CDC) and RTI International.
The Taj Mahal’s iconic marble dome and soaring minarets require regular cleaning to maintain their dazzling appearance, and scientists now know why. Researchers are pointing the finger at airborne carbon particles and dust for giving the gleaming white landmark a brownish cast.
Georgia State University has received Board of Regents approval to offer the Master of Occupational Therapy degree, the entry-level degree required for occupational therapy, making it the first public college or university in Atlanta and third in Georgia to offer an occupational therapy degree.
A research team has designed a new approach that could lead to underwater imaging lidars that are much smaller and more efficient than the current full-size systems. The new technology would allow modest-sized unmanned aerial vehicles (UAVs) carry bathymetric lidars, lowering costs substantially.
A new project will provide computational tools designed to help identify and characterize the gene diversity of the residents of microbial communities.
Promoting healthy gut microbiota, the bacteria that live in the intestine, can help treat or prevent metabolic syndrome, a combination of risk factors that increases a person’s risk for heart disease, diabetes and stroke, according to researchers at Georgia State University and Cornell University. Their findings are published in the journal Gastroenterology.
Georgia State University will revitalize an area adjacent to Woodruff Park by creating a media production center for education, research and entrepreneurship and partnerships with the Georgia film, music, games and arts industries.
A Georgia Tech professor is offering an alternative to the celebrated “Turing Test” to determine whether a machine or computer program exhibits human-level intelligence.
As part of the four-year, $2.1 million National Science Foundation research project, data analytic teams from Georgia Tech and the University of Texas, Austin, will develop algorithms and methods to convert the electronic health records data into meaningful clinical concepts or phenotypes focused on diseases and specific health traits.
Carefully employing a TNF inhibitor dose-reduction strategy can be just as effective at safely treating RA patients as regular dosing methods, while also saving approximately $7,500 per patient annually.
Inflammation related to synovitis or effusion may drive increased sensitization in knee osteoarthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with hip and knee osteoarthritis may improve their pain, stiffness and physical function with sustained physical exercise, manual therapy or both, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Physically demanding jobs may increase the effects of inflammation on the progression of ankylosing spondylitis, possibly leading to increased bone formation in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Mortality risk for patients with rheumatoid arthritis is reduced to that of the general population when patients are treated with the aim to meet a low disease activity score, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Secukinumab, an anti-IL-17A monoclonal antibody biologic drug, showed promise as a treatment for patients with active ankylosing spondylitis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Rheumatologists at Geisinger Health System in Central Pennsylvania have developed a new model of rheumatoid arthritis patient care that is designed to improve quality while reducing costs, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Baseline levels of serum interferon in rheumatoid arthritis patients may help rheumatologists determine who will have a poor response to tumor necrosis factor-alpha inhibitor drugs, and one day help rheumatologists determine the best treatment options for individual RA patients.
Women with rheumatoid arthritis are at significantly higher risk of all-cause mortality, particularly respiratory causes, compared to women without the disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Not only does treatment with tumor necrosis factor (TNF) inhibitor biologic drugs not increase the risk of congestive heart failure in people with rheumatoid arthritis, but it may decrease the incidence of this serious cardiovascular disease in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Better clinical care and compliance might prevent most gout cases that require hospitalization, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with rheumatic diseases who are treated with denosumab (Prolia®, Xgeva®) either alone, or in combination with either biologic or non-biologic disease-modifying antirheumatic drugs (DMARDs), do not appear to have a significant increased risk of infections.
Women using intrauterine devices (IUDs) may be at increased risk for producing autoantibodies related to the risk of developing rheumatoid arthritis (RA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Running as a habitual exercise at any stage in life not only does not increase a person’s risk of developing knee osteoarthritis and may even help protect a person from developing the painful disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with end-stage lung disease due to systemic sclerosis should not simply be denied lung transplantation because of short- and long-term survival concerns due to extra-pulmonary factors, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
People with rheumatoid arthritis who are currently taking biologic drugs may be safely vaccinated for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Hydroxychloroquine (Plaquenil®), especially at the higher standard dose of 400 mg per day, independently decreases the risk of cardiovascular morbidity in people with rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Raman spectroscopy (RS) used at point of service could reduce the need for inpatient admission in patients with gout and pseudogout, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
People age 30 or over with autoimmune, inflammatory diseases like rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease, may benefit from vaccinations for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Use of antibiotics is associated with an increased risk of children developing juvenile idiopathic arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
Denosumab (Prolia®, Xgeva®) reversed cortical bone loss and increased bone mineral density, lowering wrist fracture rates in women with osteoporosis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Activation of the innate immune system with the bacterial protein flagellin could prevent and cure rotavirus infection, which is among the most common causes of severe diarrhea, says a Georgia State University research team that described the method as a novel means to prevent and treat viral infection.